1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Standalone Cancer Registry Software Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Public Database 1.2.3 Commercial Database 1.3 Market by Application 1.3.1 Global Standalone Cancer Registry Software Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Healthcare Providers 1.3.4 Research Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Standalone Cancer Registry Software Market Perspective (2016-2027) 2.2 Standalone Cancer Registry Software Growth Trends by Regions 2.2.1 Standalone Cancer Registry Software Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Standalone Cancer Registry Software Historic Market Share by Regions (2016-2021) 2.2.3 Standalone Cancer Registry Software Forecasted Market Size by Regions (2022-2027) 2.3 Standalone Cancer Registry Software Industry Dynamic 2.3.1 Standalone Cancer Registry Software Market Trends 2.3.2 Standalone Cancer Registry Software Market Drivers 2.3.3 Standalone Cancer Registry Software Market Challenges 2.3.4 Standalone Cancer Registry Software Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Standalone Cancer Registry Software Players by Revenue 3.1.1 Global Top Standalone Cancer Registry Software Players by Revenue (2016-2021) 3.1.2 Global Standalone Cancer Registry Software Revenue Market Share by Players (2016-2021) 3.2 Global Standalone Cancer Registry Software Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Standalone Cancer Registry Software Revenue 3.4 Global Standalone Cancer Registry Software Market Concentration Ratio 3.4.1 Global Standalone Cancer Registry Software Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Standalone Cancer Registry Software Revenue in 2020 3.5 Standalone Cancer Registry Software Key Players Head office and Area Served 3.6 Key Players Standalone Cancer Registry Software Product Solution and Service 3.7 Date of Enter into Standalone Cancer Registry Software Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Standalone Cancer Registry Software Breakdown Data by Type 4.1 Global Standalone Cancer Registry Software Historic Market Size by Type (2016-2021) 4.2 Global Standalone Cancer Registry Software Forecasted Market Size by Type (2022-2027) 5 Standalone Cancer Registry Software Breakdown Data by Application 5.1 Global Standalone Cancer Registry Software Historic Market Size by Application (2016-2021) 5.2 Global Standalone Cancer Registry Software Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Standalone Cancer Registry Software Market Size (2016-2027) 6.2 North America Standalone Cancer Registry Software Market Size by Type 6.2.1 North America Standalone Cancer Registry Software Market Size by Type (2016-2021) 6.2.2 North America Standalone Cancer Registry Software Market Size by Type (2022-2027) 6.2.3 North America Standalone Cancer Registry Software Market Size by Type (2016-2027) 6.3 North America Standalone Cancer Registry Software Market Size by Application 6.3.1 North America Standalone Cancer Registry Software Market Size by Application (2016-2021) 6.3.2 North America Standalone Cancer Registry Software Market Size by Application (2022-2027) 6.3.3 North America Standalone Cancer Registry Software Market Size by Application (2016-2027) 6.4 North America Standalone Cancer Registry Software Market Size by Country 6.4.1 North America Standalone Cancer Registry Software Market Size by Country (2016-2021) 6.4.2 North America Standalone Cancer Registry Software Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Standalone Cancer Registry Software Market Size (2016-2027) 7.2 Europe Standalone Cancer Registry Software Market Size by Type 7.2.1 Europe Standalone Cancer Registry Software Market Size by Type (2016-2021) 7.2.2 Europe Standalone Cancer Registry Software Market Size by Type (2022-2027) 7.2.3 Europe Standalone Cancer Registry Software Market Size by Type (2016-2027) 7.3 Europe Standalone Cancer Registry Software Market Size by Application 7.3.1 Europe Standalone Cancer Registry Software Market Size by Application (2016-2021) 7.3.2 Europe Standalone Cancer Registry Software Market Size by Application (2022-2027) 7.3.3 Europe Standalone Cancer Registry Software Market Size by Application (2016-2027) 7.4 Europe Standalone Cancer Registry Software Market Size by Country 7.4.1 Europe Standalone Cancer Registry Software Market Size by Country (2016-2021) 7.4.2 Europe Standalone Cancer Registry Software Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Standalone Cancer Registry Software Market Size (2016-2027) 8.2 Asia-Pacific Standalone Cancer Registry Software Market Size by Type 8.2.1 Asia-Pacific Standalone Cancer Registry Software Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Standalone Cancer Registry Software Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Standalone Cancer Registry Software Market Size by Type (2016-2027) 8.3 Asia-Pacific Standalone Cancer Registry Software Market Size by Application 8.3.1 Asia-Pacific Standalone Cancer Registry Software Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Standalone Cancer Registry Software Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Standalone Cancer Registry Software Market Size by Application (2016-2027) 8.4 Asia-Pacific Standalone Cancer Registry Software Market Size by Region 8.4.1 Asia-Pacific Standalone Cancer Registry Software Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Standalone Cancer Registry Software Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Standalone Cancer Registry Software Market Size (2016-2027) 9.2 Latin America Standalone Cancer Registry Software Market Size by Type 9.2.1 Latin America Standalone Cancer Registry Software Market Size by Type (2016-2021) 9.2.2 Latin America Standalone Cancer Registry Software Market Size by Type (2022-2027) 9.2.3 Latin America Standalone Cancer Registry Software Market Size by Type (2016-2027) 9.3 Latin America Standalone Cancer Registry Software Market Size by Application 9.3.1 Latin America Standalone Cancer Registry Software Market Size by Application (2016-2021) 9.3.2 Latin America Standalone Cancer Registry Software Market Size by Application (2022-2027) 9.3.3 Latin America Standalone Cancer Registry Software Market Size by Application (2016-2027) 9.4 Latin America Standalone Cancer Registry Software Market Size by Country 9.4.1 Latin America Standalone Cancer Registry Software Market Size by Country (2016-2021) 9.4.2 Latin America Standalone Cancer Registry Software Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Standalone Cancer Registry Software Market Size (2016-2027) 10.2 Middle East & Africa Standalone Cancer Registry Software Market Size by Type 10.2.1 Middle East & Africa Standalone Cancer Registry Software Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Standalone Cancer Registry Software Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Standalone Cancer Registry Software Market Size by Type (2016-2027) 10.3 Middle East & Africa Standalone Cancer Registry Software Market Size by Application 10.3.1 Middle East & Africa Standalone Cancer Registry Software Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Standalone Cancer Registry Software Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Standalone Cancer Registry Software Market Size by Application (2016-2027) 10.4 Middle East & Africa Standalone Cancer Registry Software Market Size by Country 10.4.1 Middle East & Africa Standalone Cancer Registry Software Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Standalone Cancer Registry Software Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 McKesson Corporation 11.1.1 McKesson Corporation Company Details 11.1.2 McKesson Corporation Business Overview 11.1.3 McKesson Corporation Standalone Cancer Registry Software Introduction 11.1.4 McKesson Corporation Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.1.5 McKesson Corporation Recent Development 11.2 Elekta 11.2.1 Elekta Company Details 11.2.2 Elekta Business Overview 11.2.3 Elekta Standalone Cancer Registry Software Introduction 11.2.4 Elekta Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.2.5 Elekta Recent Development 11.3 C/NET Solutions 11.3.1 C/NET Solutions Company Details 11.3.2 C/NET Solutions Business Overview 11.3.3 C/NET Solutions Standalone Cancer Registry Software Introduction 11.3.4 C/NET Solutions Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.3.5 C/NET Solutions Recent Development 11.4 Electronic Registry Systems 11.4.1 Electronic Registry Systems Company Details 11.4.2 Electronic Registry Systems Business Overview 11.4.3 Electronic Registry Systems Standalone Cancer Registry Software Introduction 11.4.4 Electronic Registry Systems Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.4.5 Electronic Registry Systems Recent Development 11.5 Rocky Mountain Cancer Data Systems 11.5.1 Rocky Mountain Cancer Data Systems Company Details 11.5.2 Rocky Mountain Cancer Data Systems Business Overview 11.5.3 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Introduction 11.5.4 Rocky Mountain Cancer Data Systems Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.5.5 Rocky Mountain Cancer Data Systems Recent Development 11.6 Onco 11.6.1 Onco Company Details 11.6.2 Onco Business Overview 11.6.3 Onco Standalone Cancer Registry Software Introduction 11.6.4 Onco Revenue in Standalone Cancer Registry Software Business (2016-2021) 11.6.5 Onco Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Standalone Cancer Registry Software Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Public Database Table 3. Key Players of Commercial Database Table 4. Global Standalone Cancer Registry Software Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Standalone Cancer Registry Software Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Standalone Cancer Registry Software Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Standalone Cancer Registry Software Market Share by Regions (2016-2021) Table 8. Global Standalone Cancer Registry Software Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Standalone Cancer Registry Software Market Share by Regions (2022-2027) Table 10. Standalone Cancer Registry Software Market Trends Table 11. Standalone Cancer Registry Software Market Drivers Table 12. Standalone Cancer Registry Software Market Challenges Table 13. Standalone Cancer Registry Software Market Restraints Table 14. Global Standalone Cancer Registry Software Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Standalone Cancer Registry Software Market Share by Players (2016-2021) Table 16. Global Top Standalone Cancer Registry Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Standalone Cancer Registry Software as of 2020) Table 17. Ranking of Global Top Standalone Cancer Registry Software Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Standalone Cancer Registry Software Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Standalone Cancer Registry Software Product Solution and Service Table 21. Date of Enter into Standalone Cancer Registry Software Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 24. Global Standalone Cancer Registry Software Revenue Market Share by Type (2016-2021) Table 25. Global Standalone Cancer Registry Software Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Standalone Cancer Registry Software Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Standalone Cancer Registry Software Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Standalone Cancer Registry Software Revenue Market Share by Application (2016-2021) Table 29. Global Standalone Cancer Registry Software Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Standalone Cancer Registry Software Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 32. North America Standalone Cancer Registry Software Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Standalone Cancer Registry Software Market Size by Application (2016-2021) (US$ Million) Table 34. North America Standalone Cancer Registry Software Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Standalone Cancer Registry Software Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Standalone Cancer Registry Software Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Standalone Cancer Registry Software Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Standalone Cancer Registry Software Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Standalone Cancer Registry Software Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Standalone Cancer Registry Software Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Standalone Cancer Registry Software Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Standalone Cancer Registry Software Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Standalone Cancer Registry Software Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Standalone Cancer Registry Software Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Standalone Cancer Registry Software Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Standalone Cancer Registry Software Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Standalone Cancer Registry Software Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Standalone Cancer Registry Software Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Standalone Cancer Registry Software Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Standalone Cancer Registry Software Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Standalone Cancer Registry Software Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Standalone Cancer Registry Software Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Standalone Cancer Registry Software Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Standalone Cancer Registry Software Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Standalone Cancer Registry Software Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Standalone Cancer Registry Software Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Standalone Cancer Registry Software Market Size by Country (2022-2027) & (US$ Million) Table 61. McKesson Corporation Company Details Table 62. McKesson Corporation Business Overview Table 63. McKesson Corporation Standalone Cancer Registry Software Product Table 64. McKesson Corporation Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 65. McKesson Corporation Recent Development Table 66. Elekta Company Details Table 67. Elekta Business Overview Table 68. Elekta Standalone Cancer Registry Software Product Table 69. Elekta Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 70. Elekta Recent Development Table 71. C/NET Solutions Company Details Table 72. C/NET Solutions Business Overview Table 73. C/NET Solutions Standalone Cancer Registry Software Product Table 74. C/NET Solutions Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 75. C/NET Solutions Recent Development Table 76. Electronic Registry Systems Company Details Table 77. Electronic Registry Systems Business Overview Table 78. Electronic Registry Systems Standalone Cancer Registry Software Product Table 79. Electronic Registry Systems Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 80. Electronic Registry Systems Recent Development Table 81. Rocky Mountain Cancer Data Systems Company Details Table 82. Rocky Mountain Cancer Data Systems Business Overview Table 83. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Product Table 84. Rocky Mountain Cancer Data Systems Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 85. Rocky Mountain Cancer Data Systems Recent Development Table 86. Onco Company Details Table 87. Onco Business Overview Table 88. Onco Standalone Cancer Registry Software Product Table 89. Onco Revenue in Standalone Cancer Registry Software Business (2016-2021) & (US$ Million) Table 90. Onco Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Standalone Cancer Registry Software Market Share by Type: 2020 VS 2027 Figure 2. Public Database Features Figure 3. Commercial Database Features Figure 4. Global Standalone Cancer Registry Software Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Healthcare Providers Case Studies Figure 7. Research Centers Case Studies Figure 8. Others Case Studies Figure 9. Standalone Cancer Registry Software Report Years Considered Figure 10. Global Standalone Cancer Registry Software Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Standalone Cancer Registry Software Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Standalone Cancer Registry Software Market Share by Regions: 2020 VS 2027 Figure 13. Global Standalone Cancer Registry Software Market Share by Regions (2022-2027) Figure 14. Global Standalone Cancer Registry Software Market Share by Players in 2020 Figure 15. Global Top Standalone Cancer Registry Software Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Standalone Cancer Registry Software as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Standalone Cancer Registry Software Revenue in 2020 Figure 17. Global Standalone Cancer Registry Software Revenue Market Share by Type (2016-2021) Figure 18. Global Standalone Cancer Registry Software Revenue Market Share by Type (2022-2027) Figure 19. North America Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Standalone Cancer Registry Software Market Share by Type (2016-2027) Figure 21. North America Standalone Cancer Registry Software Market Share by Application (2016-2027) Figure 22. North America Standalone Cancer Registry Software Market Share by Country (2016-2027) Figure 23. United States Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Standalone Cancer Registry Software Market Share by Type (2016-2027) Figure 27. Europe Standalone Cancer Registry Software Market Share by Application (2016-2027) Figure 28. Europe Standalone Cancer Registry Software Market Share by Country (2016-2027) Figure 29. Germany Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Standalone Cancer Registry Software Market Share by Type (2016-2027) Figure 37. Asia-Pacific Standalone Cancer Registry Software Market Share by Application (2016-2027) Figure 38. Asia-Pacific Standalone Cancer Registry Software Market Share by Region (2016-2027) Figure 39. China Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Standalone Cancer Registry Software Market Share by Type (2016-2027) Figure 47. Latin America Standalone Cancer Registry Software Market Share by Application (2016-2027) Figure 48. Latin America Standalone Cancer Registry Software Market Share by Country (2016-2027) Figure 49. Mexico Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Standalone Cancer Registry Software Market Share by Type (2016-2027) Figure 53. Middle East & Africa Standalone Cancer Registry Software Market Share by Application (2016-2027) Figure 54. Middle East & Africa Standalone Cancer Registry Software Market Share by Country (2016-2027) Figure 55. Turkey Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Standalone Cancer Registry Software Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. McKesson Corporation Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 59. Elekta Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 60. C/NET Solutions Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 61. Electronic Registry Systems Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 62. Rocky Mountain Cancer Data Systems Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 63. Onco Revenue Growth Rate in Standalone Cancer Registry Software Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

McKesson Corporation Elekta C/NET Solutions Electronic Registry Systems Rocky Mountain Cancer Data Systems Onco